Малоизученные вопросы дерматологии: липоидный некробиоз

________________________________________________

1. Urbach E. Beitrage zu einer pfyziologishen und pathologishen Chemie der Haut. Arch Dermat Syph 1932; 166: 273–85.
2. Muller SA, Winkelman RK. Necrobiosis lipoidica diabeticorum. A clinical and pathological investigation of 171 cases. Arch Dermatol 1966; 93: 271–81.
3. O’Toole EA, Kennedy U, Nolan JJ et al. Necrobiosis lipoidica: only a minority of patients have diabetes mellitus. Br J Dermatol 1999; 140: 283–6.
4. Hammer E, Lilienthal E, Hofer SE et al. Risk factors for necrobiosis lipoidica in Type 1 diabetes mellitus. Diabet Med 2017; 34 (1): 86–92.
5. Mistry BD, Alavi A, Ali S et al. A systematic review of the relationship between glycemic control and necrobiosis lipoidica diabeticorum in patients with diabetes mellitus. Int J Dermatol 2017; 56 (12): 1319–27. DOI: 10.1111/ijd.13610
6. Boateng B, Hiller D, Albrecht HP et al. Cutaneous microcirculation in pretibial necrobiosis lipoidica. Comparative measurements of laser Doppler flux and partial pressure of oxygen in patients and in healthy volunteers. Hautarzt 1993; 44: 581–6. 
7. Muller SA, Winkelmann RK. Necrobiosis lipoidica diabeticorum histopathologic study of 98 cases. Arch Dermatol 1966; 94: 1–10.
8. Ngo B, Wigington G, Hayes K et al. Skin blood flow in necrobiosis lipoidica diabeticorum. Int J Dermatol 2008; 47: 354–8.
9. Quimby SR, Muller SA, Schroeter AL. The cutaneous immunopathology of necrobiosis lipoidica diabeticorum. Arch Dermatol 1988; 124: 1364–71.
10. Sehgal VN, Shatacharya SN, Verma P. Juvenile, inslin-dependent diabetes mellitus, type 
1-related dermatoses. JEADV 2011; 25: 625–36.
11. Krause W. Cutaneous manifestation of endocrine diseases. Berlin-Heidelberg: Springer-Verlag, 2009.
12. Tokura Y, Mizushima Y, Hata M et al. Necrobiosis lipoidica of the glans penis. J Am Acad Dermatol 2003; 49 (5): 921–4.
13. Yaṣar Ṣ, Kaynak E, Gṻneṣ P et al. Atypical localization of necrobiosis lipoidica: involvement of the face and scalp. Skin Appendage Disord 2017; 3: 92–4.
14. Weidenthaler-Barth B. Clinical and histological spectrum of palisaded granulomatous dermatitides: Granuloma annulare, necrobiosis lipoidica, rheumatoid nodules, and necrobiotic xanthogranuloma. Hautarzt 2017; 68 (7): 536–41.
15. Valecha N, Bennett G, Yip L. A granulomatous conundrum: Concurrent necrobiosis lipoidica, cutaneous sarcoidosis and erythema nodosum in a nondiabetic patient. Australas J Dermatol 2017; 58 (4): e232–e235. DOI: 10.1111/ajd.12572
16. Franklin C, Stoffels-Weindorf M, Hillen U et al. Ulcerated necrobiosis lipoidica as a rare cause for chronic leg ulcers: case report series of ten pathients. Int Wound J 2015; 12 (5): 548–54.
17. Nguyen K, Washenik K, Shupack J. Necrobiosis lipoidica diabeticorum treated with chloroquine. J Am Acad Dermatol 2002; 46 (2 Suppl. Case Reports): S34–36.
18. Kreuter A, Knierim C, Stṻcker M et al. Fumaric acid esters in necrobiosis lipoidica: results of a prospective, non-controled study. Br J Dermatol 2005; 153 (4): 802–7.
19. Aslan E, Kṏrber A, Grabbe S et al. Erfolgreiche therapie einer exulzerierten Necrobiosis lipoidica non diabeticorum mit Ciclosporin. Hautarzt 2007; 58 (8): 684–8.
20. Stanway A, Rademaker M, Newman P. Healing of the severe ulcrative necrobiosis lipoidica with cyclosporine. Australas J Dermatol 2004; 45: 119–22.
21. Durupt F, Dalle S, Derbarieux S et al. Successful treatment of necrobiosis lipoidica with antimalarial agents. Arch Dermatol 2008; 144: 118–9.
22. Kavala M, Sudogan S, Zindanci I. Significant improvement in ulcerative necrobiosis lipoidica with hydroxychloroquine. Int J Dermatol 2010; 49: 466–74.
23. Alexis AF, Strober BE. Off-label dermatologic uses of anti-TNF-a therapies. J Cutan Med Surg 2005; 9 (6): 296–302.
24. Hu S, Bevona C, Winterfield L et al. Treatment of refractory ulcerative necrobiosis lipoidica diabetoricum with infleximab: repot of a case. Arch Dermatol 2009; 145 (4): 437–9.
25. Suarez-Amor O, Perez-Bastillo A, Ruiz-Gonzalez I et al. Necrobiosis lipoidica therapy with biologicals: an ulcerated case responding to etanercept and a review of the literature. Dermatology 2010; 221: 117–21.
26. Basoulis D, Fragiadaki K, Tentolouris N et al. Anti-TNF-a treatment for recalcitrant ulcerative necrobiosis lipoidica diabetoricum: A case report and review of the literature. Metabolism 2016: 569–75.
27. Heymann WR. Necrobiosis lipoidica treated with topical tretinoin. Cutis 1996; 58: 53–4.
28. De Rie MA, Sommer A, Hoekzema R et al. Treatment of necrobiosis lipoidica with topical psoralen plus ultraviolet A. Br J Dermatol 2002; 147: 743–7.
29. Heidenheim M, Jemec GB. Successful treatment of necrobiosis lipoidica diabetoricum with photodynamic therapy. Arch Dermatol 2006; 142: 1548–50.
30. Clayton TH, Harrison PV. Successful treatment of chronic ulcerated necrobiosis lipoidica with 0,1% topical tacrolimus ointment. Br J Dermatol 2005; 152: 581–2.

________________________________________________

I.L.Sorkina1, I.M.Korsunskaya*2, E.S.Andrienko3
1. Moscow Scientific and Practical Center of Dermatology and Venereology and Cosmetology of the Department of Health of Moscow. 119071, Russian Federation, Moscow, Leninskiy pr-t, d. 17;
2. Center for Theoretical Problems of Physicochemical Pharmacology of the Russian Academy of Sciences. 119991, Russian Federation, Moscow, Leninskiy pr-t, d. 38a, korp. 1;
3. “Clinic K+31”. 119415, Russian Federation, Moscow, 
ul. Lobachevskogo, d. 42, str. 4
*marykor@bk.ru